1. Home
  2. VCEL vs CTRI Comparison

VCEL vs CTRI Comparison

Compare VCEL & CTRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • CTRI
  • Stock Information
  • Founded
  • VCEL 1989
  • CTRI 1909
  • Country
  • VCEL United States
  • CTRI United States
  • Employees
  • VCEL N/A
  • CTRI N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • CTRI
  • Sector
  • VCEL Health Care
  • CTRI
  • Exchange
  • VCEL Nasdaq
  • CTRI Nasdaq
  • Market Cap
  • VCEL 1.6B
  • CTRI 1.8B
  • IPO Year
  • VCEL 1997
  • CTRI 2024
  • Fundamental
  • Price
  • VCEL $33.59
  • CTRI $21.12
  • Analyst Decision
  • VCEL Strong Buy
  • CTRI Hold
  • Analyst Count
  • VCEL 6
  • CTRI 3
  • Target Price
  • VCEL $58.60
  • CTRI $22.00
  • AVG Volume (30 Days)
  • VCEL 703.6K
  • CTRI 2.2M
  • Earning Date
  • VCEL 11-06-2025
  • CTRI 11-05-2025
  • Dividend Yield
  • VCEL N/A
  • CTRI N/A
  • EPS Growth
  • VCEL 2045.40
  • CTRI N/A
  • EPS
  • VCEL 0.13
  • CTRI N/A
  • Revenue
  • VCEL $249,119,000.00
  • CTRI $2,711,264,000.00
  • Revenue This Year
  • VCEL $18.35
  • CTRI $7.08
  • Revenue Next Year
  • VCEL $22.26
  • CTRI $5.38
  • P/E Ratio
  • VCEL $259.38
  • CTRI N/A
  • Revenue Growth
  • VCEL 16.13
  • CTRI 2.69
  • 52 Week Low
  • VCEL $29.24
  • CTRI $14.46
  • 52 Week High
  • VCEL $63.00
  • CTRI $24.60
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 52.73
  • CTRI 51.37
  • Support Level
  • VCEL $31.34
  • CTRI $20.14
  • Resistance Level
  • VCEL $35.70
  • CTRI $21.28
  • Average True Range (ATR)
  • VCEL 1.48
  • CTRI 0.74
  • MACD
  • VCEL 0.46
  • CTRI 0.00
  • Stochastic Oscillator
  • VCEL 71.12
  • CTRI 46.69

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. It operates under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

Share on Social Networks: